Protocol Ledger

NCT07022678 · Phase III · RECRUITING

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Interventional Phase III clinical trial protocol NCT07022678 sponsored by Children's Oncology Group in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-08-14 Enrollment: 556 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07022678
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)556 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07022678
Protocol FieldVerified Registry Value
NCT IdentifierNCT07022678
Consolidated Lead SponsorChildren's Oncology Group
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment556 participants (ESTIMATED)
Registered Start Date2026-08-14
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07022678
Hospital Research SiteLocationSite Profile
Children's Hospital of AlabamaBirmingham, ALOpen Hospital Dossier ->
Arkansas Children's HospitalLittle Rock, AROpen Hospital Dossier ->
Valley Children's HospitalMadera, CAOpen Hospital Dossier ->
Kaiser Permanente-OaklandOakland, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI